title: [Benign prostatic hypertrophy: criteria and results].
abstract: CLINICAL AND ECONOMICAL SETTING: Benign prostatic adenoma, a commonly observed tumor in older men, is a major public health problem. The economic implications and the multiplicity of therapeutic alternatives require the development of criteria for assessing the effects of proposed treatments. PROSTATE EXPLORATIONS: Two categories of criteria should be determined. Firstly, objective data should be obtained on urine flow rate, post-mictional residue, prostate morphometrics and prostate specific antigen (PSA) levels. Secondly, subjective assessment is needed to determine the extent of the mictional disorder; the international prostatic symptomatic score (IPSS) is an accepted tool used world-wide.
  
  
  RESULTS
  Rigorous methodology is indispensable to improve the diagnostic and therapeutic armamentarium and achieve a better cost/benefit ratio for the management of benign prostatic hyperplasia.
authors.affiliation: Service d'Urologie, Centre hospitalo-universitaire Henri Mondor, Créteil.
authors.forename: A
authors.initials: A
authors.lastname: Hoznek
authors.forename: C C
authors.initials: CC
authors.lastname: Abbou
mesh_terms: D000328:Adult; D000368:Aged; D000375:Aging; D003362:Cost-Benefit Analysis; D003657:Decision Making; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000276:immunology*; D011468:Prostatectomy / Q000191:economics; D011470:Prostatic Hyperplasia / Q000175:diagnosis* / Q000191:economics / Q000276:immunology / Q000601:surgery
chemical_list: D017430:Prostate-Specific Antigen